To develop vaccines it is mandatory yet challenging to account for inter-individual variability during immune responses. Even in laboratory mice, T cell responses of single individuals exhibit a high heterogeneity that may come from genetic backgrounds, intraspecific processes (e.g. antigen-processing and presentation) and immunization protocols.
Introduction
Nonlinear mixed effects models have been used to analyze data in various fields 51 (Davidian and Giltinan, 2003) , especially in pharmakokinetic studies, and more recently 52
to model cell to cell variability (Almquist et al., 2015; Llamosi et al., 2016) or to study 53 tumor growth (Benzekry et al., 2014; Ferenci et al., 2017) . In immunology, Keersmaekers 54 et al. (2018) have recently studied the differences between two vaccines with nonlinear 55 mixed effects models and ordinary differential equation (ODE) models for T and B cells. 56 Jarne et al. (2017) and Villain et al. (2018) have used the same approach to investigate 57 the effect of IL7 injections on HIV+ patients to stimulate the CD4 T cell response, and 58 have identified biological processes accounting for inter-individual variability.
59
A number of models of the CD8 T cell response based on ODEs have been proposed 60 over the years. Of particular relevance here is the work of De Boer et al. (2001) , where 61 the model accounts for activated and memory cell dynamics but the influence of the 62 immunogen is imposed. Antia et al. (2003) proposed a model based on partial differential 63 equations, that includes immunogen effects and dynamics of naive, effector and memory 64 cells. These works describe different subpopulations of CD8 T cells, however most of the 65 time only total CD8 T cell counts are available to validate the models. In Crauste et al. 66 (2017), the authors generated cell counts for four subpopulations of CD8 T cells in mice 67 that they used to identify the most likely differentiation pathway of CD8 T cells after 68 immunogen presentation. This approach has led to a model of the average CD8 T cell 69 dynamics in mice after immunization and its representation as a set of nonlinear ODEs. 70 March 19, 2020 4/40
The model consists in a system of ODEs describing the dynamics of naive, early effector, 71 late effector, and memory CD8 T cell subsets and the immunogen. 72 The goal of this article is to explore the ability of a mathematical model to describe the 73 inter-individual variability observed in CD8 T cell responses, in different immunization 74 contexts, by considering parameter values drawn from probability distributions (nonlinear 75 mixed effects model). Starting from the model published in (Crauste et al., 2017) , we 76
will first select a model of the CD8 T cell immune response dynamics accounting 77 for variability in cell counts by using synthetic then experimental data, generated in 78 different immunization contexts. Second we will establish that the immunogen-dependent 79 heterogeneity influences the early phase of the response (priming, activation of naive 80 cells, cellular expansion). Finally, we will show that besides its ability to reproduce CD8 81 T cell response dynamics our model is able to predict individual dynamics of responses 82 to similar immunizations, hence providing an efficient tool for investigating CD8 T cell 83 dynamics and inter-individual variability. 84 Results
85
Model selection on synthetic data 86 In Crauste et al. (2017) , System (3) (see Section Models of CD8 T cell dynamics) has 87 been shown to be able to describe average dynamics of CD8 T cell immune responses, 88 when CD8 T cells go through 4 differentiation stages: naive, early-then late-effector 89 cells, and memory cells (see Section Data). Here System (3) is reduced in order to 90 obtain a mixed effect model of CD8 T cell immune response whose parameters are 91 correctly estimated on ideal data. Ideal data are generated by simulating ODE models 92 and accounting for more individuals and time points than with real, biological data: we 93 call them"synthetic data", see Section Model selection on synthetic data. 94 We use Synth data sets 1 to 4 ( is performed with SAEM algorithm (Monolix, 2019), see Section Parameter estimation. 96
Using the procedure described in Section Model selection on synthetic data, based in 97 particular on the use of the relative standard error (RSE) defined in (4) that informs on 98 the confidence in the estimation, we iteratively remove parameters (see Table S2 ) µ E I (estimated value = 0.2 vs true value = 1.8 cell −1 day −1 , RSE = 61%), 100 µ E L (estimated value = 0.3 vs true value = 3.6 cell −1 day −1 , RSE = 17%), and 101 µ I (estimated value = 0.013 vs true value = 0.055 day −1 , RSE = 9%).
102
They are all related to death rates, of late effector cells (µ E L ) and of the immunogen 103 (µ I , µ E I ). In each case, the model still accounts for death of late effector cells and 104 of the immunogen, via parameters µ L L and µ L I . Nonlinear mixed effects models avoid 105 redundancy in the description of biological processes, thus they allow reliable parameter 106 estimation using synthetic data. Parameter values are available in Table S1 . 107 This leads to a reduction of the initial 12-parameters System (3) to the 9-parameters 108
System (1),
For the sake of simplicity the parameters are renamed in System (1) Parameter estimation is performed using the SAEM algorithm (Monolix, 2019) and, 115
following the procedure described in Section Model selection on biological data, leads to 116 further reduction of the model. Using in vivo data to estimate parameter values provides 117 a priori less information than synthetic data. Hence, it might be necessary to reduce 118 the number of parameters to ensure correct estimations, either mean values or random 119 effects, similarly to what has been done in the previous section.
120
The first step in the model reduction procedure leads to an estimated value of 121 parameter µ L close to zero (2 × 10 −8 cell −1 day −1 ), with a RSE > 100%, see Step 1. Hence parameter µ L is removed, and the estimation is performed again with the 123 updated model. We observe that all mean value parameters have now RSE < 30%, so 124
we conclude that their estimations are reliable (Table 2, Step 2 ).
125
In the second step of the procedure however, several random effects have large RSE 126 and high shrinkages ( 
Bars highlight fixed parameters within the population. This system enables to describe 138 VV data set 1 and its inter-individual variability. The inter-individual variability is 139 entirely contained in the activation rate of naive cells (δ N E ), the mortality-induced 140 regulation of effector cells (µ E ), and the dynamics of the immunogen (ρ I and µ I ). small for all subpopulations: a N = a M = 0.3 log10(cells), a E = a L = 0.4 log10(cells)). 148
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Parameter values are given in Table 3 . even with a small amount of data points, thanks to the use of nonlinear mixed effects 158 models and the parameter estimation procedure. By focusing first on the population 159 dynamics (based on a collection of individual dynamics), the method enables to recover 160 the whole individual dynamics. This is a huge advantage when data sampling frequency 161 is low.
162
Similar good results are obtained for Tumor data set 1 (see Fig 2. B and parameter 163 values in Table 3 ). Therefore System (2) difference is observed between VV and Tumor data sets obtained with System (2), rather 174 than between these values and the one obtained in Crauste et al. (2017) . This may 175 highlight a potential difference in the capacity of the two immunogens (VV and Tumor) 176
to activate naive cells. This is investigated in the next section. 
Immunization-dependent parameters
Parameter comparison between immunizations. VV and Tumor induced im-179 munizations differ in many aspects. VV immunizations are virus-mediated, use the 180 respiratory tract to infect cells, and trigger an important innate response. Tumor immu-181 nizations involve eukaryotic cells bearing the same antigen, use subcutaneous routes, and 182 induce a reduced innate response. From the independent estimations on VV and Tumor 183 data sets (Table 3) , we compute differences between estimated values of fixed effects. 184
Differences are large for parameters -in decreasing order -δ N E (62%), ρ E (60%), µ N 185 (47%), ρ I (37%), and δ LM (30%). These large differences may result from biological 186 processes involved in the CD8 T cell response that differ depending on the immunogen. 187
Consequently, combining both data sets (VV and Tumor) as observations may 188 highlight which parameters have to be significantly different to describe both data sets. 189
Parameters depending on immunization. To perform this analysis, we combine 190 VV and Tumor data sets 1 and we include a categorical covariate into the model to 191 estimate parameter values (see Section Parameter estimation). Covariates allow to 192 identify parameter values that are significantly different between two CD8 activation 193 conditions (tumors vs virus).
194
A covariate is added to the fixed effects of the five parameters that showed the larger 195 differences in the initial estimation: δ N E , ρ E , µ N , ρ I and δ LM . This results in the 196 estimation of two different parameter values for parameters ρ E , µ N and δ LM (that are 197 fixed within the population) and two probability distributions with different mean values 198 for parameters δ N E and ρ I (that vary within the population). 199 One may note that adding a covariate increases the number of parameters to estimate. 200 However, the number of parameters is not doubled, since we assumed that parameters 201 without covariates are shared by both immunization groups. In addition, the data set is 202 larger, since it combines VV and Tumor measurements. Hence the number of parameters 203 with respect to the amount of data remains reasonable.
204
From this new estimation, we conclude that among the five selected parameters the 205 covariates of only four of them are significantly different from zero: δ N E , ρ E , µ N , and 206 δ LM (Wald test, see Table S3 and Section Parameter estimation). The estimation is 207 therefore performed a second time assuming ρ I distribution is the same in both groups. 208 Then the Wald test indicates that the remaining covariates are significantly different 209 from zero (Table 4 ). Table 4 gives the estimated values of all parameters in both groups. Regarding 216 parameters that do not vary within the population, it is required for parameters µ N , 217 δ LM and ρ E to be different to describe each data set, and this difference is accounted 218 for with a covariate parameter. Noticeably, using categorical covariates mostly improves 219 the confidence in the estimation, as highlighted by either RSE values in the same range 220
March 19, 2020 13/40 (µ N , ρ E ) or improved (all other parameters) RSE values (Tables 3 and 4 ).
In summary, we identified parameters whose values are significantly different according 222 to the immunogen used to activate CD8 T cells. These parameters correspond to the 223 dynamics of naive cells (µ N ), their activation (δ N E ), the proliferation of early effector 224 cells (ρ E ), and differentiation to memory cells (δ LM ). We hence conclude that different 225 immunizations affect the CD8 T cell activation process in the first phase of the response 226 (priming, activation of naive cells, expansion of the CD8 T cell population) as well as 227 the development of the memory population, and induce various degrees of variability in 228 these responses through the activation of naive cells.
229
Predicting dynamics following VV and Tumor immunizations 230
To challenge System (2) and the estimated parameters (Table 4) , we compare simulated 231 outputs to an additional data set, not used for data fitting up to this point, of both VV 232
and Tumor immunizations, VV data set 2 and Tumor data set 2 (Table 1 and Section A 233 posteriori model validation on biological data).
234
We already know the probability distribution of parameters (Table 4) Starting from the model described in Crauste et al. (2017) that could efficiently 255 describe CD8 T cell dynamics, at the level of average population cell-counts in peripheral 256 blood, we built and validated this nonlinear mixed effects model in a step-wise fashion. 257
The system was first reduced to ensure correct parameter estimation when confronted 258 to ideal, highly informative data. We next identified parameters -hence biological 259 processes -that vary between individuals, and parameters that can be fixed within 260 the population to explain biological data measured in different immunization contexts 261 (virus and tumor). Finally, by adding a categorical covariate we identified immunization-262 dependent parameters.
263
Noteworthy, from a biological point of view, the removal of one parameter during 264 model reduction (for example, the death rate of late effector cells) must not be understood 265 as if the corresponding process is not biologically meaningful. Based on the available 266 data, our methodology found that some processes are non-necessary in comparison with 267 the ones described by the system's equations.
268
Similarly, parameters characterizing immunogen dynamics vary within the population 269 whereas model reduction led to remove the variability of equivalent processes (proliferation 270 for instance) in CD8 T cell dynamics. It is likely that this is due to a lack of experimental 271 measures on immunogen dynamics (whether virus load evolution or tumor growth), and 272 one cannot conclude that inter-individual variability mostly comes from immunogen 273 dynamics. Information on immunogen dynamics, when available, could significantly 274 improve parameter estimation and help refining the information on inter-individual 275 variability during CD8 T cell responses. Two of the three differentiation rates (early effector cell differentiation in late effector 283 cells, and late effector cell differentiation in memory cells) do not need to vary to 284 describe our data sets. This robustness of the differentiation rates is in good agreement 285
with the auto-pilot model that shows that once naive CD8 T cells are activated their 286 differentiation in memory cells is a steady process (Kaech and Ahmed, 2001; Stipdonk 287 et al., 2001) .
288
Eventually, using nonlinear mixed effects models and an appropriate parameter 289 estimation procedure, we were able to quantitatively reproduce inter-individual vari-290 ability in two different immunization contexts (VV and Tumor) and provide predictive 291 population dynamics when confronted to another data set (for both immunogens). This 292 demonstrates the robustness of the model.
293
The addition of a categorical covariate allowed us to identify parameters that are 294 immunization-dependent. Interestingly they control the activation of the response 295
(priming, differentiation of naive cells, expansion of effector cells) as well as the generation 296 of memory cells. This is again in good agreement with the biological differences that 297 characterize the two immunogens used in this study. Indeed, pathogen-associated 298 molecular patterns (PAMP) associated with vaccinia virus will activate a strong innate 299
immune response that will provide costimulatory signals that in turn will increase the 300 efficiency of naive CD8 T cell activation (Iwasaki and Medzhitov, 2015) . In contrast, when 301 primed by tumor cells CD8 T cells will have access to limited amount of costimulation 302 derived from damage associated molecular patterns (Yang et al., 2017) . The amount 303 of costimulation will also control the generation of memory cells (Mescher et al., 2006) . 304
Focusing on average CD8 T cell behaviors (not shown) highlights stronger responses 305
following VV immunization, characterized by a faster differentiation of naive cells and a 306 higher peak of the response (at approximately 3 × 10 5 cells compare to 10 5 cells for the 307 Tumor induced response). Also, in average, more memory cells are produced following 308 VV immunization. Hence the addition of covariates to the model parameters has allowed 309 to identify biologically relevant, immunogen-dependent parameters.
310
Using covariates has additional advantages. First, they allow to consider a larger data 311 set (in our case, the combination of two data sets) without adding too many parameters to 312 estimate (4 covariates in our case). This is particularly adapted to situations where only 313
March 19, 2020 17/40 and without covariate. In both cases using the covariate (and thus a larger data set) 318 improved the quality of individual fits, and in the case of Individual 1 generated more 319 relevant dynamics with a peak of the response occurring earlier, before day 10pi. No 320 individual fit has been deteriorated by the use of a covariate (not shown).
321
Finally, CD8 T cell response dynamics to both VV and Tumor immunogens were 322 well captured for data sets that had not been used to perform parameter estimation 323 March 19, 2020 19/40 (Jubin et al., 2012 
(3)
The variables N , E, L and M denote the four CD8 T cell subpopulation counts, naive, 389 early effector, late effector, and memory cells respectively (see Section Data), and I is 390
the immunogen load.
391
The immunogen load dynamics are normalized with respect to the initial amount 392 Model selected on synthetic data. Model (3) has been obtained by fitting average 408 dynamics of a CD8 T cell immune response (Crauste et al., 2017) . When confronting 409 this model to heterogeneous data of individual CD8 T cell dynamics and using mixed 410 effects modeling, we have to verify that assumptions of the mixed effects model (see 411
Section Nonlinear mixed effects models) are valid. Using synthetic data and the procedure 412
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This model is dynamically similar to System (3), but in order to correctly fit synthetic 415 data and to satisfy the assumptions of mixed effects modeling, parameters µ E L , µ E I and 416 µ I have been removed: it was not possible to accurately estimate them to non-zero true 417 values. For the sake of simplicity the parameters are renamed in System (1): µ L L = µ L 418 and µ L I = µ I . System (1) is defined by 9 parameters.
419
Model selected on biological data. When using biological, experimental data 420 instead of synthetic data, not as many time points and measurements can be obtained 421 (in particular with in vivo data) so the dynamical model may easily be over-informed 422 (too many parameters compared to the size of the sampling). Using System (1), the 423 confrontation with VV data set 1 leads to the reduced System (2),
System
(2) has 8 parameters (µ L has been removed from System (1) 
Nonlinear mixed effects models
Nonlinear mixed effects models allow a description of inter-individual heterogeneity 429 within a population of individuals (here, mice). The main idea of the method is to 430 consider that since all individuals belong to the same population they share common 431 characteristics. These common characteristics are called "fixed effects" and characterize 432 an average behavior of the population. However, each individual is unique and thus 433 differs from the average behavior by a specific value called "random effect".
434
This section briefly describes our main hypotheses. Details on the method can be 435 found in Delyon et al. (1999) , Kuhn and Lavielle (2005) , Samson and Donnet (2007) , 436 Lavielle (2014) .
437
Each data set {y i,j , i = 1, ..., N ind , j = 1, ..., n i } is assumed to satisfy
where y i,j is the j th observation of individual i, N ind is the number of individuals within 440 the population and n i is the number of observations for the i th individual.
441
The function f accounts for individual dynamics generated by a mathematical model. 442
In this work f is associated with the solution of a system of ODE, see Section Models of 443 CD8 T cell dynamics. The function f depends on known variables, denoted by x i,j , and 444 parameters of the i th individual, denoted by ψ i .
445
Individual parameters ψ i are assumed to be split into fixed effects (population-446 dependent effects, average behavior) and random effects (individual-dependent effects). 447
If ψ k i denotes the k-th parameter characterizing individual i, then it is assumed that
where the vector of parameters p pop = (p k pop ) k models the average behavior of the 450 population, and η i = (η k i ) k represents how the individual i differs from this average 451 behavior. Variables η k i ∼ N (0, ω 2 k ), and they are assumed independent and identically 452 distributed. The variance ω 2 k quantifies the variability of the k-th parameter within the 453 population. From now on we will denote by ω 2 the vector of variances (ω 2 k ) k . Parameters 454
The residual errors, combining model approximations and measurement noise, are 456 denoted by aε i,j . They quantify how the model prediction is close to the observation. 457
Residual errors are assumed independent, identically and normally distributed, i.e 458 ε i,j ∼ N (0, 1). Moreover, the random effects η i and the residual errors aε i,j are 459 mutually independent. In this work, we assume a constant error model, with a constant a, 460 for all cell populations, since they are all observed in log10 scale. The error parameter is 461 estimated for each subpopulation (naive cells -a N ; early effector cells -a E ; late effector 462 cells -a L ; memory cells -a M ). When data on the immunogen dynamics are available 463 (only when using synthetic data), we assume a proportional error for the immunogen 464
which is observed, so that a I = b I f . 465 We will write that a parameter is fixed within the population if all individuals have 466 the same value for this parameter. On the contrary, if the variance ω 2 k of a parameter 467 is non-zero, then this parameter will account for inter-individual variability within the 468 population. Covariates. In order to study whether differences observed in parameter values be-482 tween VV and Tumor data sets ( To tackle this question, we first pool together VV and Tumor data sets 1. Second, 486 using this full data set, we estimate parameter values by assuming that fixed effects 487 of some Tumor-associated parameters are different from those of the corresponding 488 VV-associated parameters.
489
To introduce categorical covariates in our mixed effect model, we assume that if an 490 individual is either in Tumor or VV data set then the probability distribution of its 491 individual parameter vector ψ i has a different mean. We write
where c i equals 0 if individual i is in VV data set 1 and 1 if it is in Tumor data set 1, and 494 β = (β k ) k is a vector of covariate parameters. We test whether the estimated covariate 495 parameterβ is significantly different from zero with a Wald test, using Monolix (2019) 496 software, and we use a p-value threshold at 0.05.
497
Parameters (p pop , ω 2 , a, β) are then characterizing cell population dynamics for both 498 VV and Tumor immunogens. If the estimated vectorβ is significantly different from 499 zero, then part of the experimentally observed variability could be explained by the 500 immunogen.
501
Model selection on synthetic data 502 Model selection relies on criteria that allow to evaluate to which end a model appropriately 503 satisfies a priori assumptions. For instance, one usually requires a model to correctly fit 504 the data, and uses so-called quality of fit criteria, and/or requires that initial modeling 505 assumptions are satisfied.
506
Here, we do not use quality of fit criteria to select a model because all models correctly 507 fit data (see Paragraph Model selection below). Instead, we focus on the capacity of the 508 parameter estimation procedure to correctly estimate model parameters. To do so, we 509 first use synthetic data (see Paragraph Generation of synthetic data below). Because 510 we know the exact true parameter values used to generate the data, to evaluate the 511 correctness of estimated parameter values we rely on:
512
-the relative difference between the estimated parameter value and the true value, 513
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θ , θ a parameter,θ its estimated value.
A large RSE indicates a poor estimation of the parameter.
517
-the η-shrinkage value (denoted throughout this manuscript as the shrinkage value), 518 defined as
where var(η i ) is the empirical variance of the random effect η i and ω 2 the estimated 520 variance of the parameter; Large values of the shrinkage characterize individual 521 estimates shrunk towards the conditional mode of the parameter distribution.
522
We decided not to consider the mathematical notion of identifiability here. Indeed, 523 studying identifiability in nonlinear mixed effect models is a complicated, open question 524 that has been discussed for instance in Lavielle and Aarons (2016) . Approaches based 525 on the Fisher Information Matrix (RSE) have been proposed and are often used for 526 evaluating identifiability of population parameters, while analysis of the shrinkage 527 allows to investigate individual parameters identifiability, and we used such methods in 528 this work.
529
Generation of synthetic data. Using a dynamical model (for instance, System (3)), 530
we generate a set of data associated to solutions of the model, where all the parameters 531 are drawn from known log-normal distributions. Parameters p k varying in the population 532 satisfy log(p k ) ∼ N (log(m k ), 0.1 2 ). The standard deviation is fixed to the value 0.1 to 533 generate heterogeneity, and values of medians m k are given in Table S1 . A multiplicative 534 white noise modifies model's outputs in order to mimic real measurements (we consider 535 a white noise with standard deviation 0.2).
536
These data consist of time points and measurements for the 4 subpopulations of CD8 537
T cell counts (in log10 scale) and the immunogen load. These are called synthetic data, 538
and these sets of data are referred to as Synth data set X, with X= 1, . . . , 4 ( Table 1) . 539
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We generate synthetic data for 100 individuals, cell counts are sampled at days 4, 540 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, 30pi (cf. Fig S1 to S4) . In agreement with real 541 biological data, we assume that all cell counts below 100 cells are not measured, and 542 account for missing data. For the immunogen load, values lower than 0.1 are also not 543 considered.
544
Model selection. Model selection on synthetic data is performed in 4 steps:
545
Step 1 Select an initial model 546
Step 2 Estimate parameter values using SAEM (Monolix, 2019)
547
Step 3 Remove (priority list):
548
-parameters whose estimated value is different from their true value, and the 549 RSE is larger than 5%
550
-random effect of parameters with shrinkage larger than 30%.
551
Step 4 Select a model with all parameters correctly estimated 552
In Step 1, model (3) is used, with all parameters varying within the population. This 553 makes 29 parameters to estimate: 12 mean values, 12 random effects, 5 error parameters. 554
In Step 3, based on the estimations performed in Step 2, we iteratively remove parameters that are not correctly estimated. To do so, we first focus on parameters that are not estimated to their true value (which is known) and whose RSE is larger than 5%.
We consider that the estimated value is different from the true value if E rr > 10%, with
Once all parameters are correctly estimated according to the two first criteria, we remove 555 random effects of parameters with shrinkage larger than 30%. 556 One must note that every time a parameter is removed from the model (mean value 557 or random effect) then new synthetic data are generated using the same protocol as 558 described above, and Step 2 is performed again.
559
Errors are known when using synthetic data: since a normal noise, proportional to 560 the observation, modifies each observation then there is a constant error on observations 561
March 19, 2020 27/40 of cell counts in log10 scale, and a proportional error on the immunogen load. As 562 mentioned in Section Nonlinear mixed effects models, we assume a constant error for all 563 cell populations and a proportional error for the immunogen load. Diagnostic tools in 564
Monolix (2019) show that error models are correct (not shown here).
565
Quality of fit criteria do not provide relevant information in our case: the Bayesian 566
Information Criterion (BIC) reaches very low values, even for the initial model (3), 567
whereas observations vs predictions graphs show that the number of outliers is not 568 modified by simplifications of the model. Hence, we do not use quality of fit criteria to 569 select a model. In
Step 4, we select a model based on the chosen criteria that insure the 570 correct estimation of all its parameters and its reduced shrinkage when confronted to a 571 set of synthetic data.
572
Model selection on biological data 573 Biological data are the ones introduced in Section Data. Compared to synthetic data, 574 they provide less observations, hence it may not be possible to correctly estimate as 575 many parameters as in the synthetic data case.
576
Model selection on biological data is also performed in 4 steps:
577
Step 1 Select an initial model 578
579
580
-parameters whose RSE is larger than 100%
581
-random effect of parameters with shrinkage larger than 75%
582
Step 4 Select a model with RSE and shrinkages low 583
In Step 1, model (1) is used, with all parameters varying within the population. This 584 makes 23 parameters to estimate: 9 mean values, 9 random effects, 5 error parameters. 585
This model is the one selected on synthetic data (see Section Model selection on synthetic 586 data).
587
In
Step 3, we iteratively remove parameters that are not correctly estimated. We first 588 focus on parameters that are not estimated with a high confidence, that is RSE > 100%. 589
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Once all parameters are correctly estimated, we remove random effects of parameters 590 with shrinkage larger than 75%.
591
The error model is not known, so we use the same error model as for synthetic data: 592 a constant error for all cell populations (note that no data on immunogen is available, so 593 the error parameter for the immunogen is not estimated). Diagnostic tools in Monolix 594
(2019) show that assuming constant error models is acceptable (not shown here).
595
A posteriori model validation on biological data 596 In Section Predicting dynamics following VV and Tumor immunizations, the model 597 selected on biological data is compared to data that were not used for parameter 598 estimation. These data are presented hereafter.
599
In order to assess the model ability to characterize and predict immune response 600 dynamics we compare our results to additional experiments, VV data set 2 and Tumor 601 data set 2 (see Table 1 and Section Data), similar to the ones used to estimate parameters 602 (VV and Tumor data sets 1). CD8 T cell counts of naive, early and late effector, and 603 memory cells have been measured following VV and tumor immunizations, on days 4, 6, 604 7, 8, 11, 13, 15, 21, 28, 42pi. 605 The probability distribution of parameters (mean values, random effects) are known 606 since we have estimated them on VV and Tumor data sets 1 (Section Model selection on 607 biological data). These parameters are not estimated on the validation data. We use 608 them to estimate the individual parameter values that fit individual behaviors of these 609 new data sets (see Section Parameter estimation). March 19, 2020 34/40 
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Supplementary File 1. Contains the following tables and figures. (4), 'r.e.' stands for random effect, and the shrinkage is defined in (5).
Note that values (mean values and random effects) of parameters µ E E , µ L L , µ E L , µ E I and µ L I have to be multiplied by 10 −5 (for µ L I ), 10 −6 (for µ E E and µ L L ), 10 −7 (for µ E I ), and 10 −8 (for µ E L ). Units are omitted for the sake of clarity. Fig. S1 . Synth data set 1. These data have been obtained by simulating System (3) with parameter values in Table S1 and using a multiplicative white noise, as detailed in Section Model selection on synthetic data. 100 individuals are simulated and first observations are on day 4 pi for cell populations and the immunogen. Then measurements are on days 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, and 30 pi. All cell counts below 100 cells are not measured. For the immunogen load, values lower than 0.1 are also not considered. Table S1 , and using a multiplicative white noise, as detailed in Section Model selection on synthetic data. See Fig. S1 for details. Fig. S3 . Synth data set 3. These data have been obtained by simulating a reduced System (3), with parameter values in Table S1 , and using a multiplicative white noise, as detailed in Section Model selection on synthetic data. See Fig. S1 for details. Fig. S4 . Synth data set 4. These data have been obtained by simulating a reduced System (3), with parameter values in Table S1 , and using a multiplicative white noise, as detailed in Section Model selection on synthetic data. See Fig. S1 (1) -VV data set 1 and System (2) -Tumor data set 1 and System (2) -VV and Tumor data set 1, System (2) and 4 categorical covariates Tables   Table 1 . Data sets (details in Sections Data, Models of CD8 T cell dynamics and Model selection on synthetic data). Short Name Description VV data set 1 CD8 T cell counts of 59 individual mice inoculated intra-nasally with 2 × 10 5 pfu of a vaccinia virus (VV) expressing the NP68 epitope ; naive, early and late effector, and memory cell counts have been measured up to day 47pi VV data set 2 Similar to VV data set 1 (15 individual mice) ; CD8 T cell counts of naive, early and late effector, and memory cells have been measured following VV immunization, up to day 42pi Tumor data set 1 CD8 T cell counts of 55 individual mice subcutaneously inoculated with 2.5 × 10 6 EL4 lymphoma cells expressing the NP68 epitope ; naive, early and late effector, and memory cell counts have been measured up to day 47pi Tumor data set 2 Similar to Tumor data set 1 (20 individual mice); CD8 T cell counts of naive, early and late effector, and memory cells have been measured following Tumor immunization, up to day 42pi Synth data sets 1 to 4 Synthetic data sets generated with System (3) and its subsequent simplifications (see Section Model selection on synthetic data), consisting in CD8 T cell counts of naive, early and late effector, and memory cells on days 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 18, 20, 25, 30pi for 100 individuals cell counts (log10) 0.4 (10) 0.5 (9) a L cell counts (log10) 0.4 (9) 0.6 (8) a M cell counts (log10) 0.3 (10) 0.5 (10) - 10 −5 cell −1 day −1 2.9 (18) 2.9 (18) ω µ I 10 −5 cell −1 day −1 0.9 (15) 0.9 (15) -Residual errors a N cell counts (log10) 0.5 (10) 0.5 (10) a E cell counts (log10) 0.5 (7) 0.5 (7) a L cell counts (log10) 0.5 (6) 0.5 (6) a M cell counts (log10) 0.4 (8) 0.4 (8) -
